Two-step development of a pituitary adenoma: From hyperprolactinemic syndrome to Cushing's disease

被引:13
作者
Gheri, RG
Boddi, W
Ammannati, F
Olivotto, J
Nozzoli, C
Franchi, A
Bordi, L
Luisi, MLE
Mennonna, P
机构
[1] UNIV FLORENCE, AZIENDA OSPED CAREGGI, DIV MED, I-50139 FLORENCE, ITALY
[2] UNIV FLORENCE, AZIENDA OSPED CAREGGI, DIV NEUROCHIRURG, I-50139 FLORENCE, ITALY
[3] UNIV FLORENCE, AZIENDA OSPED CAREGGI, IST ANAT PATOL, I-50139 FLORENCE, ITALY
关键词
hyperprolactinemia; Cushing's disease; silent adenoma; pituitary adenoma;
D O I
10.1007/BF03346911
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In this report we describe the case of a young female patient with amenorrhea-galactorrhea syndrome apparently due to pituitary PRL-secreting adenoma who, after three years of dopaminergic therapy without any shrinkage of the tumor, developed true Cushing's disease. Progression from hyperprolactinemia to hypersecretion of ACTH has been rarely described and it may be due to different possibilities. However, histopathological and immunohistochemical studies of the adenoma showed a pattern of PRL negative and ACTH positive cells, excluding mixed pituitary tumor. In order to explain the progression from hyperprolactinemia with amenorrhea-galactorrhea to an ACTH hypersecretion syndrome, it must be hypothesized either pituitary stalk compression or the influence of paracrine regulation factor(s) (such as Galanine) due to an "initially silent" corticotropinoma. This case confirms that the presence of hyperprolactinemia in a patient with pituitary tumor and amenorrhea-galactorrhea syndrome is insufficient to confidently conclude for prolactinoma. Furthermore, it underlines the importance both of clinically monitoring the patient with prolactin pituitary adenoma if dopaminergic therapy does not reduce tumor volume, and of accurately and repeatedly measuring the other pituitary hormonal secretions. (C) 1997, Editrice Kurtis.
引用
收藏
页码:240 / 244
页数:5
相关论文
共 24 条
[1]  
Berthezene F, 1974, Rev Otoneuroophtalmol, V46, P295
[2]  
BESSER M, 1993, ACTA ENDOCRINOL-COP, V129, P27
[3]   MULTIHORMONAL RESPONSE TO CRH IN A PATIENT WITH CUSHING SYNDROME AND A PITUITARY-ADENOMA PRODUCING ACTH AND GH [J].
BUGALHO, MJGM ;
NUNES, JFM ;
SOBRINHO, LG ;
MEDINA, E ;
CAMPOS, JAM ;
DASILVA, CG ;
CLODE, AL .
ACTA ENDOCRINOLOGICA, 1993, 128 (03) :289-292
[4]   RECURRENT GOITER, HYPERTHYROIDISM, GALACTORRHEA AND AMENORRHEA DUE TO A THYROTROPIN AND PROLACTIN-PRODUCING PITUITARY TUMOR [J].
HORN, K ;
ERHARDT, F ;
FAHLBUSCH, R ;
PICKARDT, CR ;
WERDER, KV ;
SCRIBA, PC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1976, 43 (01) :137-143
[5]  
HSU DW, 1991, AM J PATHOL, V138, P897
[6]   ENHANCED PROLACTIN RESPONSIVENESS TO GALANIN IN PATIENTS WITH CUSHINGS-DISEASE [J].
INVITTI, C ;
GIRALDI, FP ;
TAGLIAFERRI, A ;
SCACCHI, M ;
DUBINI, A ;
CAVAGNINI, F .
CLINICAL ENDOCRINOLOGY, 1993, 39 (02) :213-216
[7]  
KNOTOGHEORGOS G, 1992, NEUROSURGERY, V30, P919
[8]   MULTIPLE ADENOMAS OF THE HUMAN PITUITARY - A RETROSPECTIVE AUTOPSY STUDY WITH CLINICAL IMPLICATIONS [J].
KONTOGEORGOS, G ;
KOVACS, K ;
HORVATH, E ;
SCHEITHAUER, BW .
JOURNAL OF NEUROSURGERY, 1991, 74 (02) :243-247
[9]   GROWTH-HORMONE (GH) AND PROLACTIN (PRL) GENE-EXPRESSION AND IMMUNOREACTIVITY IN GH-PRODUCING AND PRL-PRODUCING HUMAN PITUITARY-ADENOMAS [J].
LI, J ;
STEFANEANU, L ;
KOVACS, K ;
HORVATH, E ;
SMYTH, HS .
VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1993, 422 (03) :193-201
[10]   CUSHINGS-DISEASE AND HYPERPROLACTINEMIA DUE TO A MIXED ACTH-SECRETING AND PROLACTIN-SECRETING PITUITARY MACROADENOMA [J].
MAHLER, C ;
VERHELST, J ;
KLAES, R ;
TROUILLAS, J .
PATHOLOGY RESEARCH AND PRACTICE, 1991, 187 (05) :598-602